- Pattern Hair Loss
in Men - Hair Loss
in Women - Telogen Effluvium
Hair Loss - Anagen Effluvium
Hair Loss - Iron Deficiency
& Hair Loss - Protein Deficiency
& Hair Loss - Thyroid Deficiency
& Hair Loss - Micronutrient Deficiency
& Hair Loss - Alopecia Areata
- Scarring Hair Loss Disorders
- Congenital
Hair Follicle Deficiency - Hair Restoration
- Follicular Unit Transfer
(FUT) - Follicular Unit Extraction
(FUE) - DHT: The Hair Killer
- Propecia (Finasteride)
& Avodart (Dutasteride) - Minoxidil & Rogaine
- Compounded
Topical Medications - Platelet-Rich Plasma
(PRP) - Low-Level Laser Therapy
(LLLT) - Biotin
(Vitamin B7) - Scalp Micro Pigmentation
(SMP)
Minoxidil & Rogaine
Minoxidil is a medication that dilates blood vessels, originally developed in the late 1950’s by Upjohn
Company. Minoxidil was first approved by the FDA in 1979 for treatment of high blood pressure, in the form of an oral tablet. Studies conducted for Minoxidil as an anti-hypertensive medication showed unexpected hair growth and led to its development as a treatment for hair loss. The over-the-counter product, Rogaine for men, contains 5% Minoxidil. Rogaine for women contains 2% Minoxidil.
In contrast to Finasteride and Dutasteride, Minoxidil does not affect DHT. Minoxidil appears to improve hair loss by its effect on hair growth; increasing the Anagen or growth phase of the hair growth cycle. This allows the miniaturized follicle to grow longer and gain greater diameter. The longer, thicker hairs have more volume and provide better coverage.
Disclaimer
Please consult with your physician before considering any of the drugs or treatments discussed on this website